Pathogenic variants in BRCA1 and BRCA2 and several other genes are risk factors for ovarian cancer [2], conferring a 17–44% lifetime risk of ovarian cancer for females with pathogenic variants in the BRCA1 or BRCA2 genes, as well as increased risks for breast (72%) and other cancers [3]. This evidence concerns the gene BRCA1 and cancer.